Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma

Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma

Galactose-modified selenium nanoparticles (GA-SeNPs) loading with doxorubicin (DOX) for hepatocellular carcinoma (HCC) therapy was investigated in this paper. Selenium nanoparticles (SeNPs) were modified with galactose as tumor targeting moiety to fabricate tumor-targeted delivery carrier GA-SeNPs,...

Full description

Bibliographic Details
Main Authors: Yu Xia, Jiayu Zhong, Mingqi Zhao, Ying Tang, Ning Han, Liang Hua, Tiantian Xu, Changbing Wang, Bing Zhu
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Drug Delivery
Subjects:
anticancer
tumor targeting
chemotherapy
apoptosis
nanocarrier
Online Access:http://dx.doi.org/10.1080/10717544.2018.1556359

Internet

http://dx.doi.org/10.1080/10717544.2018.1556359

Similar Items